- Home
- ACDC vs DNTH Comparison
ACDC vs DNTH Comparison
Compare ACDC & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACDC
- DNTH
- Stock Information
- Founded
- ACDC 2014
- DNTH 2015
- Country
- ACDC United States
- DNTH United States
- Employees
- ACDC N/A
- DNTH N/A
- Industry
- ACDC Oilfield Services/Equipment
- DNTH Biotechnology: Pharmaceutical Preparations
- Sector
- ACDC Energy
- DNTH Health Care
- Exchange
- ACDC Nasdaq
- DNTH Nasdaq
- Market Cap
- ACDC 764.1M
- DNTH 657.0M
- IPO Year
- ACDC 2022
- DNTH N/A
- Fundamental
- Price
- ACDC $4.40
- DNTH $19.59
- Analyst Decision
- ACDC Hold
- DNTH Strong Buy
- Analyst Count
- ACDC 5
- DNTH 8
- Target Price
- ACDC $7.40
- DNTH $54.33
- AVG Volume (30 Days)
- ACDC 760.2K
- DNTH 251.8K
- Earning Date
- ACDC 05-07-2025
- DNTH 05-16-2025
- Dividend Yield
- ACDC N/A
- DNTH N/A
- EPS Growth
- ACDC N/A
- DNTH N/A
- EPS
- ACDC N/A
- DNTH N/A
- Revenue
- ACDC $2,209,700,000.00
- DNTH $6,235,000.00
- Revenue This Year
- ACDC $0.00
- DNTH N/A
- Revenue Next Year
- ACDC $4.29
- DNTH N/A
- P/E Ratio
- ACDC N/A
- DNTH N/A
- Revenue Growth
- ACDC N/A
- DNTH 120.63
- 52 Week Low
- ACDC $3.83
- DNTH $13.37
- 52 Week High
- ACDC $9.75
- DNTH $32.27
- Technical
- Relative Strength Index (RSI)
- ACDC 42.03
- DNTH 45.90
- Support Level
- ACDC $3.83
- DNTH $20.76
- Resistance Level
- ACDC $5.01
- DNTH $22.14
- Average True Range (ATR)
- ACDC 0.42
- DNTH 1.50
- MACD
- ACDC 0.06
- DNTH -0.13
- Stochastic Oscillator
- ACDC 43.51
- DNTH 5.53
About ACDC ProFrac Holding Corp.
ProFrac Holding Corp is engaged in providing hydraulic fracturing, completion services, and other complementary products and services to upstream oil and gas companies engaged in the exploration and production of North American unconventional oil and natural gas resources. Its operations are focused in West Texas, East Texas/Louisiana, South Texas, Oklahoma, Uinta, and Appalachian. The company operates in three segments: Stimulation Services, Proppant Production, and Manufacturing. Stimulation services, which generate the majority of the revenue for the company operate a fleet of mobile hydraulic fracturing units and other auxiliary equipment that generates revenue by providing stimulation services.
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.